sarcoma
FDA Approves Tecentriq Hybreza for Subcutaneous Injection for All Adult Indications of IV Tecentriq
The FDA has approved Tecentriq Hybreza for subcutaneous injection as the intravenous formulation of Tecentriq.
SEPTEMBER 16, 2024
FDA Grants Accelerated Approval to Tecelra for Unresectable or Metastatic Synovial Sarcoma
The FDA has granted accelerated approval to afamitresgene autoleucel (Tecelra, Adaptimmune LLC), a ...
AUGUST 31, 2024
Load more